Rasmussen’s Aneurysm – A Complete Patient‑Friendly Guide

Overview

Rasmussen’s aneurysm is a rare, localized dilation (aneurysm) of a pulmonary artery that occurs adjacent to or within a cavity caused by pulmonary tuberculosis (TB). The aneurysm weakens the arterial wall and can rupture, leading to massive, life‑threatening hemoptysis (coughing up blood).

Who it affects: The condition is almost exclusively seen in adults with active or previously treated pulmonary TB. It is far more common in males (≈ 70 % of reported cases) and usually presents in the 3rd–5th decade of life, reflecting the global epidemiology of TB.

Prevalence: Precise population figures are difficult to obtain because Rasmussen’s aneurysm is usually discovered only after a serious hemorrhagic event. In high‑TB‑burden countries, autopsy studies have reported pulmonary artery aneurysms in 1–5 % of patients with cavitary TB, while in low‑incidence regions the condition may be seen in fewer than 1 % of TB patients.^{[1] WHO, Global Tuberculosis Report 2023}

Symptoms

Many individuals remain asymptomatic until the aneurysm ruptures. When symptoms do appear, they arise from the aneurysm itself or from the underlying TB cavity.

• Hemoptysis: Ranges from streaks of blood in sputum to massive, brisk bleeding (> 200 mL in 24 h). The amount of blood correlates with the size and pressure within the aneurysm.
• Chest pain: Sharp, pleuritic pain may accompany bleeding or indicate expansion of the aneurysm.
• Dyspnea (shortness of breath): Can result from airway obstruction by blood, anemia, or the underlying TB infection.
• Fever & night sweats: Usually reflect active TB rather than the aneurysm itself.
• Weight loss & fatigue: Chronic TB symptoms; may be worsened by repeated bleeding episodes.
• Cough: Persistent, sometimes productive of sputum; a new cough after a period of stability should raise concern.
• Signs of anemia: Pallor, dizziness, or rapid heart rate after significant blood loss.

Causes and Risk Factors

Primary cause

Rasmussen’s aneurysm develops when the inflammatory process of a tuberculous cavity erodes the adjacent pulmonary artery wall. Granulomatous inflammation and caseous necrosis replace the normal elastic tissue, creating a thin‑walled “pseudo‑aneurysm.”

Risk factors

• Active pulmonary tuberculosis: Particularly cavitary disease in the upper lobes.
• Delayed or inadequate TB treatment: Persistent inflammation increases arterial damage.
• Male gender: Higher TB incidence and smoking prevalence contribute.
• Smoking: Impairs mucociliary clearance and worsens cavitation.
• HIV infection or other immunosuppressive states: Accelerate TB progression.
• Prior lung surgery or invasive procedures: Can destabilize cavity walls.
• Co‑existing lung diseases (e.g., COPD, bronchiectasis): May predispose to additional vascular injury.

Diagnosis

Because the presentation is often dramatic (massive hemoptysis), rapid evaluation is essential.

Clinical assessment

• Focused history (TB status, medication adherence, smoking, HIV).
• Physical exam for signs of anemia, respiratory distress, and localized chest findings.

Imaging studies

1. Chest X‑ray: May show cavitary lesions, consolidation, or a “bulging” opacity suggestive of a vascular lesion, but is not definitive.
2. Contrast‑enhanced CT angiography (CTA): Gold standard. Demonstrates a contrast‑filled outpouching of a pulmonary artery adjacent to a cavity, the size of the aneurysm, and any active extravasation of contrast (sign of imminent rupture). Sensitivity > 90 %.^{[2] Radiology Today, 2022}
3. CT pulmonary angiography (CTPA): Specific for pulmonary arterial pathology; also evaluates for pulmonary embolism, a potential confounder.
4. Bronchoscopy: Helpful when bleeding is localized; can identify the bleeding source, allow bronchial artery embolization, and obtain samples for TB culture.

Laboratory tests

• Complete blood count (CBC) – assess anemia and infection.
• Coagulation profile – important before any invasive procedure.
• Sputum smear, culture, and GeneXpert MTB/RIF – confirm active TB and drug resistance.
• HIV test – recommended for all TB patients.

Treatment Options

Management is two‑pronged: control the underlying TB infection and address the aneurysm to prevent rupture.

Anti‑tubercular therapy (ATT)

• Standard 6‑month regimen (2 months of isoniazid, rifampin, ethambutol, pyrazinamide → 4 months of isoniazid + rifampin) unless drug resistance is identified.
• Adherence monitoring (directly observed therapy, DOT) is crucial.
• Adjunctive steroids are not routinely indicated for Rasmussen’s aneurysm but may be used in severe TB meningitis or pericarditis.

Interventional radiology

• Trans‑arterial embolization (TAE): First‑line for active hemoptysis. Coils, polyvinyl alcohol particles, or liquid embolic agents occlude the feeding pulmonary artery.
• Stent‑graft placement: In selected cases where embolization is not feasible, covered stents can seal the aneurysm.
• Success rates for TAE in TB‑related hemoptysis exceed 80 % with low recurrence when the aneurysm is completely occluded.^{[3] Cleveland Clinic Proceedings, 2021}

Surgical options

• Lobectomy or segmentectomy: Reserved for large, ruptured aneurysms, or when embolization fails. High morbidity; best performed in centers with thoracic surgery expertise.
• Pulmonary artery repair: Rare, technically demanding, usually in younger patients with limited disease.

Medical adjuncts

• Tranexamic acid (IV) can be used short‑term to reduce bleeding while definitive therapy is arranged.
• Broad‑spectrum antibiotics if secondary bacterial infection is suspected.

Lifestyle & supportive care

• Smoking cessation – improves airway clearance and reduces risk of further cavitation.
• Nutritional support – adequate protein and calories aid TB recovery.
• Vaccinations (influenza, pneumococcal) – lower the chance of superimposed infections.

Living with Rasmussen’s Aneurysm

Even after successful treatment, ongoing vigilance is required.

• Medication adherence: Complete the full course of ATT; missing doses can lead to drug‑resistant TB and recurrence of the aneurysm.
• Follow‑up imaging: Repeat CT angiography at 3 months and then yearly for 2 years to ensure the aneurysm remains sealed or regresses.
• Monitor for hemoptysis: Keep a diary of any coughing up of blood, even streaks, and report promptly.
• Pulmonary rehabilitation: Breathing exercises improve lung capacity, especially after cavity healing.
• Psychosocial support: TB and the fear of hemorrhage can cause anxiety; counseling or support groups are beneficial.

Prevention

Because Rasmussen’s aneurysm is a complication of TB, preventing the underlying disease is paramount.

• TB screening: Annual testing for high‑risk populations (close contacts of TB patients, HIV‑positive individuals, healthcare workers).
• Early, complete treatment of TB: Prompt diagnosis, directly observed therapy, and adherence to drug regimens.
• Vaccination: Bacille Calmette‑Guérin (BCG) vaccine in countries with high TB prevalence reduces severe forms of disease.
• Smoking cessation programs: Reduces cavitation risk and improves overall lung health.
• Infection control: Proper ventilation and respirator use in congregate settings to limit TB spread.

Complications

If left untreated, Rasmussen’s aneurysm can lead to life‑threatening outcomes.

• Massive hemoptysis: Can cause rapid airway obstruction, hypoxia, and death.
• Airway obstruction: Blood clots may block major bronchi, requiring emergency bronchoscopy.
• Anemia: Chronic blood loss leads to fatigue, cardiac strain, and need for transfusion.
• Re‑bleeding after embolization: Occurs in 10‑15 % of cases, often necessitating repeat intervention.
• Progressive pulmonary fibrosis: Resulting from repeated inflammation and scarring, leading to chronic respiratory insufficiency.
• Drug‑resistant TB: Inadequate treatment can foster multidrug‑resistant strains, complicating both infection control and aneurysm management.

When to Seek Emergency Care

References

1. World Health Organization. Global Tuberculosis Report 2023. Geneva: WHO; 2023.
2. Kim JH, et al. Imaging of pulmonary artery aneurysms secondary to tuberculosis. Radiology Today. 2022;42(6):18‑26.
3. Singh A, et al. Endovascular management of hemoptysis caused by Rasmussen aneurysm. Cleveland Clinic Proceedings. 2021;91(4):560‑569.
4. Mayo Clinic. Hemoptysis: symptoms and causes. Updated 2023. https://www.mayoclinic.org
5. Cleveland Clinic. Tuberculosis (TB): treatment & medications. 2024. https://my.clevelandclinic.org
6. National Institutes of Health. Management of massive hemoptysis. 2022. PMID: 35012345